Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;149(7):655-62.
doi: 10.1001/jamasurg.2013.5067.

Pressure control during preparation of saphenous veins

Affiliations

Pressure control during preparation of saphenous veins

Fan Dong Li et al. JAMA Surg. 2014 Jul.

Abstract

Importance: Long-term patency of human saphenous veins (HSVs) used as autologous conduits for coronary artery bypass grafting (CABG) procedures remains limited because of vein graft failure (VGF). Vein graft failure has been reported to be as high as 45% at 12 to 18 months after surgery and leads to additional surgery, myocardial infarction, recurrent angina, and death. Preparation of HSVs before implantation leads to conduit injury, which may promote VGF.

Objectives: To investigate whether pressure distension during vein graft preparation leads to endothelial injury and intimal thickening and whether limiting intraluminal pressure during pressure distension by using a pressure release valve (PRV) preserves endothelial function and prevents neointima thickening.

Design, setting, and participants: Segments of HSVs were collected in a university hospital from 13 patients undergoing CABG procedures immediately after harvest (unmanipulated [UM]), after pressure distension (after distension [AD]), and after typical intraoperative surgical graft preparation (after manipulation [AM]). Porcine saphenous veins (PSVs) from 7 healthy research animals were subjected to manual pressure distension with or without an in-line PRV that prevents pressures of 140 mm Hg or greater. Endothelial function of the HSVs and PSVs was determined in a muscle bath, endothelial integrity was assessed, and intimal thickening in PSVs was evaluated after 14 days in organ culture.

Main outcomes and measures: Endothelial function was measured in force, converted to stress, and defined as the percentage relaxation of maximal phenylephrine-induced contraction. Endothelial integrity was assessed by immunohistologic examination. Neointimal thickness was measured by histomorphometric analysis.

Results: Pressure distension of HSVs led to decreased mean (SEM) endothelial-dependent relaxation (5.3% [2.3%] for AD patients vs 13.7% [2.5%] for UM patients; P < .05) and denudation. In the AM group, the function of the conduits was further decreased (-3.2% [3.2%]; P < .05). Distension of the PSVs led to reduced endothelial-dependent relaxation (7.6% [4.4%] vs 61.9% [10.2%] in the control group; P < .05), denudation, and enhanced intimal thickening (15.0 [1.4] µm vs 2.2 [0.8] µm in the control group; P < .05). Distension with the PRV preserved endothelial-dependent relaxation (50.3% [9.6%]; P = .32 vs control), prevented denudation, and reduced intimal thickening (3.4 [0.8] µm; P = .56 vs controls) in PSVs.

Conclusions and relevance: Use of a PRV during graft preparation limits intraluminal pressure generated by manual distension, preserves endothelial integrity, and reduces intimal hyperplasia. Integration of this simple device may contribute to improved long-term vein graft patency.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Drs Brophy and Cheung-Flynn have a financial relationship with Vasoprep Surgical.

Figures

Figure 1
Figure 1. Impairment of Contractility and Vasorelaxation of Human Saphenous Vein (HSV) Graft by Intraoperative Manual Distension and Graft Preparation
HSVs were collected after harvest (unmanipulated [UM]), after pressure distension (after distension [AD]), and after typical intraoperative surgical graft preparation (after manipulation [AM]). Phenylephrine (PE)-induced contraction (A), endothelial-dependent relaxation (B), and endothelial-independent relaxation (C) were determined in the muscle bath. Error bars indicate SEM.
Figure 2
Figure 2. Distortion of Luminal Area and Disruption of Endothelial Integrity of Human Saphenous Veins by Intraoperative Manual Distension
Unmanipulated (A and C) and after-distension (B and D) segments were immunostained for CD31 (original magnification ×50 [A and B] and ×200 [C and D]). L indicates lumen; M, media.
Figure 3
Figure 3. Reduction of Intraluminal Pressure During Manual Distension of Human Saphenous Veins With a Pressure Release Valve (PRV)
Intraluminal pressure was measured by connecting the distal end of the conduits to a manometer during manual distension in the absence (manual) or presence of the PRV. Inset: Photograph of the PRV.
Figure 4
Figure 4. Preservation of Contractility and Vasorelaxation of Porcine Saphenous Veins With the Pressure Release Valve (PRV) During Manual Distension
The porcine saphenous veins were left undistended (control) or subjected to pressure distension in the absence (distended) or presence of the PRV. Phenylephrine (PE)-induced contraction (A), endothelial-dependent relaxation (B), and endothelial-independent relaxation (C) were determined in the muscle bath. Error bars indicate SEM.
Figure 5
Figure 5. Preservation of Endothelial Integrity and Prevention of Intimal Hyperplasia In Vitro in Porcine Saphenous Veins (PSVs) With a Pressure Release Valve (PRV) During Manual Distension
A, Immediately after distension, PSVs were fixed for endothelial nitric oxide synthase (eNOS) and CD31 immunostaining. B, Organ cultured PSVs were fixed for the Verhoeff-van Gieson stain (VVG) to measure intimal thickness. Arrowheads indicate areas of disruption. Error bars indicate SEM. Scale bar = 100 μm.

Similar articles

Cited by

References

    1. Alexander JH, Hafley G, Harrington RA, et al. PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294(19):2446–2454. - PubMed
    1. Conte MS, Bandyk DF, Clowes AW, et al. PREVENT III Investigators. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43(4):742–751. - PubMed
    1. Kouzi-Koliakos K, Kanellaki-Kyparissi M, Marinov G, et al. Prebypass histological and ultrastructural evaluation of the long saphenous vein as a predictor of early graft failure. Cardiovasc Pathol. 2006;15(6):336–346. - PubMed
    1. Conte MS. Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes? Semin Vasc Surg. 2009;22(4):227–233. - PubMed
    1. LoGerfo FW, Haudenschild CC, Quist WC. A clinical technique for prevention of spasm and preservation of endothelium in saphenous vein grafts. Arch Surg. 1984;119(10):1212–1214. - PubMed

Publication types

-